Instil Bio Inc (TIL): Next-Year EPS Estimate 52.06%
As of 2026-03-27, Instil Bio Inc (TIL) has a next-year EPS growth estimate of 52.06%.
On 2026-03-24, analyst consensus for TIL's next-year EPS growth shifted from 57.56% to 52.06% — a negative change of 5.50 percentage points. The revised estimate has been sustained across 8 subsequent trading sessions.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 52.06%
- EPS growth this year
- N/A
- EPS next quarter (est)
- N/A
- Last price
- $7.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-03-27 | 52.06% | N/A | N/A | $7.79 |
| 2026-03-26 | 52.06% | N/A | N/A | $8.36 |
| 2026-03-26 | 52.06% | N/A | N/A | $8.36 |
| 2026-03-26 | 52.06% | N/A | N/A | $8.36 |
| 2026-03-25 | 52.06% | N/A | N/A | $8.60 |
| 2026-03-25 | 52.06% | N/A | N/A | $8.60 |
| 2026-03-25 | 52.06% | N/A | N/A | $8.60 |
| 2026-03-24 | 52.06% | N/A | N/A | $8.56 |
| 2026-03-24 | 57.56% | N/A | N/A | $8.56 |
| 2026-03-24 | 57.56% | N/A | N/A | $8.56 |
| 2026-03-23 | 57.56% | N/A | N/A | $8.42 |
| 2026-03-20 | 52.06% | N/A | N/A | $8.55 |
| 2026-03-19 | 57.56% | N/A | N/A | $8.48 |
| 2026-03-18 | 52.06% | N/A | N/A | $8.34 |
| 2026-03-17 | 52.06% | N/A | N/A | $8.57 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Instil Bio Inc's next-year EPS growth estimate?▾
As of 2026-03-27, Instil Bio Inc (TIL) has a next-year EPS growth estimate of 52.06%, based on analyst consensus.
When was the latest EPS estimate revision for TIL?▾
The most recent revision occurred on 2026-03-24, when analysts adjusted the next-year EPS growth estimate from 57.56% to 52.06%.
What sector and industry does Instil Bio Inc belong to?▾
Instil Bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TIL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Instil Bio Inc (TIL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports